Fangfang Lv

1.6k total citations
65 papers, 840 citations indexed

About

Fangfang Lv is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Fangfang Lv has authored 65 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 11 papers in Genetics. Recurrent topics in Fangfang Lv's work include Lymphoma Diagnosis and Treatment (28 papers), Cancer Treatment and Pharmacology (13 papers) and Viral-associated cancers and disorders (10 papers). Fangfang Lv is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Cancer Treatment and Pharmacology (13 papers) and Viral-associated cancers and disorders (10 papers). Fangfang Lv collaborates with scholars based in China, United States and Chile. Fangfang Lv's co-authors include Haiyi Guo, Chunlei Zheng, Xinmin Zhao, Feng‐Qing Wang, Jun Qian, Lei Chen, Li Jin, Chuan Li, Haiyan Yang and Dehui Zou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fangfang Lv

61 papers receiving 830 citations

Peers

Fangfang Lv
Comparison fields: 5 of 87
  • Oncology 432
  • Pathology and Forensic Medicine 275
  • Pulmonary and Respiratory Medicine 225
  • Molecular Biology 215
  • Genetics 139
Sheng Yang China
Luca Paoluzzi United States
L. Austin Doyle United States
J. Garcia‐Vargas United States
Lawrence Garbo United States
Dana S. Thompson United States
Masafumi Takimoto Japan
Bin Meng China
Corrine Zarwan United States
W. Li China
Sheng Yang China View profile →
Citations per field, relative to Fangfang Lv
Fangfang Lv · 1×
Citations per year, relative to Fangfang Lv
Fangfang Lv · 1×

Countries citing papers authored by Fangfang Lv

Since Specialization
Citations

This map shows the geographic impact of Fangfang Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Lv more than expected).

Fields of papers citing papers by Fangfang Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Lv. The network helps show where Fangfang Lv may publish in the future.

Co-authorship network of co-authors of Fangfang Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Lv. A scholar is included among the top collaborators of Fangfang Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Lv. Fangfang Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 1
4 1
5 1
6 3
7 1
8 0
9 2
10 2
11 1
12 5
13 6
14 111
15 10
16 8
17 6
18 5
19 219
20 16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026